Przejdź do zawartości
Merck

Characterization of microminipigs as an in vivo experimental model for cardiac safety pharmacology.

Journal of pharmacological sciences (2017-03-02)
Suchitra Matsukura, Yuji Nakamura, Xin Cao, Takeshi Wada, Hiroko Izumi-Nakaseko, Kentaro Ando, Hiroshi Yamazaki, Atsushi Sugiyama
ABSTRAKT

We pharmacologically characterized microminipigs as an in vivo experimental model by assessing cardiovascular effects of pilsicainide, verapamil and E-4031, which can preferentially inhibit cardiac Na

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Pilsicainide hydrochloride, ≥98% (HPLC)